EVs Are Out of the Headlines and That's Exactly Why These 2 Stocks Are Buys

QuantumScape is forecast to grow revenue from under $1M in 2026 to $545M in 2028 as it commercializes QSE-5 solid-state batteries and begins licensing to Volkswagen and other automakers; the stock trades at a $3.9B market cap (~7x 2028 sales) with an expected shift toward higher-margin licensing. ChargePoint operated 385,000 charging ports at fiscal‑2026 year‑end (access to 1.37M+ via roaming), active users rose 8% to 1.48M, and analysts expect revenue to climb from $411M to $590M by 2028 (~13% CAGR); its market cap is roughly $125M, trading at under 1x current sales.

Analysis

QuantumScape’s roadmap is a tech-licensing optionality play more than a battery factory story — that subtlety matters for winners and losers. If licensing scales, profit pools shift toward IP owners, tooling suppliers (dry electrode, lithium-metal handling equipment) and materials licensors while large-cap cell builders that front-loaded gigafactory capex see lower-than-expected returns; OEMs that secure early licensing deals (and the supply chains they bring) will gain a durable cost advantage. ChargePoint’s expanding footprint is creating a two-sided market dynamic: hosts capture site-level economics while the network captures recurring software/roaming revenue, but the real margin lever is utilization — incremental utilization converts infrastructure capex into recurring margin at very high IRR.

Key risks are timing and proof points. For QuantumScape the single biggest value-derailer is a delayed or low-yield ramp: each 6–12 month slip in automotive qualification compounds licensing revenue deferral and forces re-rating; independent cycle-life and safety certifications are binary catalysts within an 18–36 month horizon. For ChargePoint the short-run risk is utilization and financing: sub-30% monetized utilization or a need to raise equity at distressed multiples can wipe out the narrative even while ports grow; near-term catalysts to watch are large fleet hosting contracts, meaningful growth in roaming take-rates, or new public charging subsidies.

The consensus underappreciates asymmetric upside from IP-led commercialization and overestimates the inevitability of captive OEM networks crowding out independent hosts. That makes structured, time-limited long exposure attractive: you want to own convexity into VW/third-party licensing announcements while hedging calendar risk and funding positions from write-ups on incumbent EV ecosystem winners. For ChargePoint, treat equity exposure as conditional on improving utilization metrics and proof of positive contribution margins at scale — otherwise size with tight downside protection.

Key Decisions for Investors

• Long QS Jan-2028 call spread (buy QS Jan-2028 LEAPS calls, sell a higher-strike Jan-2028 call) to express asymmetric upside if licensing/validation milestones hit in 2027–2028. Target position: 2–3% portfolio notional; max loss = premium paid; upside scenario >2–4x if OEM licensing ramps and independent third-party validation is published within 18 months.
• Long CHPT equity sized 1–2% of portfolio with protective 9–12 month puts (buy-to-hedge ~30–40% OTM) to cap downside while participating in utilization-driven upside. Entry trigger: post-earnings dip >10% or evidence of two consecutive quarters of improving monetized utilization; risk/reward: asymmetric 2x upside over 12–24 months vs limited downside to put cost.
• Pair-funded asymmetric: finance part of QS longs by selling a disciplined TSLA call spread (sell TSLA Jan-2028 mid calls, buy further OTM Jan-2028 calls) to express a view that wider OEM access to better batteries narrows Tesla’s premium. Use proceeds to reduce net premium paid for QS exposure; cap funded trade risk to defined credit spread and size conservatively (net exposure ≤2% portfolio).